Search research articles
Contact Us
Filters
Showing results (1-10 of 168) with videos related to
Page
of 17
Sort By:
Current Opinion in Neurology
|
April 2, 2016
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives
Orhan Aktas, Philipp Albrecht, Hans-Peter Hartung
Neurology(R) Neuroimmunology & Neuroinflammation
|
March 3, 2021
Neuroprotective Properties of 4-Aminopyridine
Michael Dietrich, Hans-Peter Hartung, Philipp Albrecht
Trends in Molecular Medicine
|
June 24, 2025
Gastric cancer: from biomarkers to functional precision medicine
Philipp Albrecht, Ekin Karabati, Matthias P Ebert, et al.
Current Opinion in Neurology
|
January 30, 2019
Assessing the anterior visual pathway in optic neuritis: recent experimental and clinical aspects
Michael Dietrich, Orhan Aktas, Hans-Peter Hartung, et al.
Journal of Neurology
|
January 22, 2020
Effective long-term treatment with incobotulinumtoxin (Xeomin®) without neutralizing antibody induction: a monocentric, cross-sectional study
Harald Hefter, Raphaela Brauns, Beyza Ürer, et al.
Toxins
|
August 6, 2021
Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot Drop
Harald Hefter, Werner Nickels, Dietmar Rosenthal, et al.
Der Nervenarzt
|
June 12, 2020
[Ocrelizumab for treatment of multiple sclerosis]
Jonas Graf, Philipp Albrecht, Norbert Goebels, et al.
Scientific Reports
|
December 28, 2021
Patch individual filter layers in CNNs to harness the spatial homogeneity of neuroimaging data
Fabian Eitel, Jan Philipp Albrecht, Martin Weygandt, et al.
Journal of Neuroinflammation
|
July 20, 2020
Comparison of different optomotor response readouts for visual testing in experimental autoimmune encephalomyelitis-optic neuritis
Christina Hecker, Michael Dietrich, Andrea Issberner, et al.
CNS & Neurological Disorders Drug Targets
|
January 8, 2010
Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target
Philipp Albrecht, Jan Lewerenz, Sonja Dittmer, et al.
Page
of 17
Search research articles
Search
Showing results (1-10 of 168) with videos related to
Sort By:
Page
of 17
Current Opinion in Neurology
|
April 2, 2016
Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives
Orhan Aktas, Philipp Albrecht, Hans-Peter Hartung
Neurology(R) Neuroimmunology & Neuroinflammation
|
March 3, 2021
Neuroprotective Properties of 4-Aminopyridine
Michael Dietrich, Hans-Peter Hartung, Philipp Albrecht
Trends in Molecular Medicine
|
June 24, 2025
Gastric cancer: from biomarkers to functional precision medicine
Philipp Albrecht, Ekin Karabati, Matthias P Ebert, et al.
Current Opinion in Neurology
|
January 30, 2019
Assessing the anterior visual pathway in optic neuritis: recent experimental and clinical aspects
Michael Dietrich, Orhan Aktas, Hans-Peter Hartung, et al.
Journal of Neurology
|
January 22, 2020
Effective long-term treatment with incobotulinumtoxin (Xeomin®) without neutralizing antibody induction: a monocentric, cross-sectional study
Harald Hefter, Raphaela Brauns, Beyza Ürer, et al.
Toxins
|
August 6, 2021
Continuous Increase of Efficacy under Repetitive Injections of Botulinum Toxin Type/A beyond the First Treatment for Adult Spastic Foot Drop
Harald Hefter, Werner Nickels, Dietmar Rosenthal, et al.
Der Nervenarzt
|
June 12, 2020
[Ocrelizumab for treatment of multiple sclerosis]
Jonas Graf, Philipp Albrecht, Norbert Goebels, et al.
Scientific Reports
|
December 28, 2021
Patch individual filter layers in CNNs to harness the spatial homogeneity of neuroimaging data
Fabian Eitel, Jan Philipp Albrecht, Martin Weygandt, et al.
Journal of Neuroinflammation
|
July 20, 2020
Comparison of different optomotor response readouts for visual testing in experimental autoimmune encephalomyelitis-optic neuritis
Christina Hecker, Michael Dietrich, Andrea Issberner, et al.
CNS & Neurological Disorders Drug Targets
|
January 8, 2010
Mechanisms of oxidative glutamate toxicity: the glutamate/cystine antiporter system xc- as a neuroprotective drug target
Philipp Albrecht, Jan Lewerenz, Sonja Dittmer, et al.
Page
of 17